Viatris Inc
General
Total Cases34
Active Cases4
Patents15
Ratings
Experience
Grade
Trend
DCT
L5
B
PTAB
L5
A
CAFC
L5
A
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
---|---|---|
01/03/25 | Proposed Findings of Fact by Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 01/03/2025) | |
01/03/25 | OPENING Post-Trial Brief for U.S. Patent No. 11,096,918, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 1/3/2025 (nms). (Entered: 01/03/2025) | |
12/31/24 | Official Transcript of Bench Trial held on 12/13/24 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/21/2025. Redacted Transcript Deadline set for 1/31/2025. Release of Transcript Restriction set for 3/31/2025. (Triozzi, Heather) (Entered: 12/31/2024) | |
12/31/24 | Official Transcript of Bench Trial held on 12/12/24 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/21/2025. Redacted Transcript Deadline set for 1/31/2025. Release of Transcript Restriction set for 3/31/2025. (Triozzi, Heather) (Entered: 12/31/2024) | |
12/31/24 | Official Transcript of Bench Trial held on 12/11/24 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/21/2025. Redacted Transcript Deadline set for 1/31/2025. Release of Transcript Restriction set for 3/31/2025. (Triozzi, Heather) (Entered: 12/31/2024) | |
12/31/24 | Official Transcript of Bench Trial held on 12/10/24 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/21/2025. Redacted Transcript Deadline set for 1/31/2025. Release of Transcript Restriction set for 3/31/2025. (Triozzi, Heather) (Entered: 12/31/2024) | |
12/31/24 | Official Transcript of Bench Trial held on 12/09/24 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/21/2025. Redacted Transcript Deadline set for 1/31/2025. Release of Transcript Restriction set for 3/31/2025. (Triozzi, Heather) (Entered: 12/31/2024) | |
12/20/24 | Admitted Trial Exhibits for Bench Trial held 12/10/2024 - 12/13/2024, Regarding U.S. Patent Nos. 11,058,667 and 11,096,918, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 12/20/2024 (nms). (Entered: 12/20/2024) | |
12/18/24 | NOTICE of Lodging of MSN's Demonstratives used at the trial held 12/9/2024, through 12/13/2024, by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3)(Weinblatt, Richard) Modified on 12/19/2024 (nms). (Entered: 12/18/2024) | |
12/18/24 | REDACTED VERSION of [433] Amended Exhibits, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 12/19/2024 (nms). (Entered: 12/18/2024) |